Aryl boronate functionalized polymers for treating obesity

Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Aftertreated polymer

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S078180, C424S078260, C525S337000, C528S004000, C528S008000, C528S394000

Reexamination Certificate

active

07041280

ABSTRACT:
Disclosed are polymers comprising one or more phenyl boronate ester, boronamide or boronate thioester groups. The phenyl boronate ester, boronamide and boronate thioester groups are represented by one of the following structural formulas:Ar in Structural Formulas (I) and (II) is substituted or unsubstituted; and each Z is —O—, —NH— or —S— and is independently selected. Pharmaceutically acceptable salts of the polymer are also included. The aryl boronate ester, boronamide or boronate thioester can be cleaved to release the corresponding aryl boronic acid.Also disclosed are pharmaceutical compositions comprising the polymers of the present invention and a pharmaceutically acceptable carrier or diluent; and methods of treating a subject for obesity with the polymers of the present invention.

REFERENCES:
patent: 4496722 (1985-01-01), Gallop et al.
patent: 4634722 (1987-01-01), Gallop
patent: 5290817 (1994-03-01), Petraitis
patent: 5356893 (1994-10-01), Bradshaw et al.
patent: 5472628 (1995-12-01), Panandiker et al.
patent: 5487888 (1996-01-01), Mandeville, III et al.
patent: 5496545 (1996-03-01), Holmes-Farley et al.
patent: 5607669 (1997-03-01), Mandeville, III et al.
patent: 5618530 (1997-04-01), Mandeville, III et al.
patent: 5624963 (1997-04-01), Mandeville, III et al.
patent: 5631371 (1997-05-01), Bloczynski
patent: 5667775 (1997-09-01), Holmes-Farley et al.
patent: 5679717 (1997-10-01), Mandeville, III et al.
patent: 5693675 (1997-12-01), Mandeville, III et al.
patent: 5702696 (1997-12-01), Mandeville, III et al.
patent: 5702952 (1997-12-01), Sundrehagen et al.
patent: 5703188 (1997-12-01), Mandeville, III et al.
patent: 5726343 (1998-03-01), Ziegler et al.
patent: 5739318 (1998-04-01), Frantzen et al.
patent: 5840677 (1998-11-01), Nielsen et al.
patent: 5866568 (1999-02-01), Bradbury et al.
patent: 5900475 (1999-05-01), Mandeville, III et al.
patent: 5925379 (1999-07-01), Mandeville, III et al.
patent: 5972873 (1999-10-01), Nielsen et al.
patent: 5985938 (1999-11-01), Holmes-Farley et al.
patent: 6034129 (2000-03-01), Mandeville, III et al.
patent: 6083495 (2000-07-01), Holmes-Farley et al.
patent: 6083497 (2000-07-01), Huval et al.
patent: 6184363 (2001-02-01), Shoichet et al.
patent: 6197967 (2001-03-01), Vollmueller et al.
patent: 6203785 (2001-03-01), Holmes-Farley et al.
patent: 6264937 (2001-07-01), Mandeville, III et al.
patent: 6299868 (2001-10-01), Jozefiak et al.
patent: 3930663 (1990-11-01), None
patent: 4307243 (1993-10-01), None
patent: 0 354 434 (1990-02-01), None
patent: 0 478 050 (1992-04-01), None
patent: 0 495 627 (1992-07-01), None
patent: 0 571 928 (1993-12-01), None
patent: 1 072 597 (2001-01-01), None
patent: 2 276 162 (1994-09-01), None
patent: 2000-336045 (2000-12-01), None
patent: WO 92/08722 (1992-05-01), None
patent: WO 94/14803 (1994-07-01), None
patent: WO 95/01326 (1995-01-01), None
patent: WO 95/11243 (1995-04-01), None
patent: WO 95/20569 (1995-08-01), None
patent: WO 96/02288 (1996-02-01), None
patent: WO 96/17833 (1996-06-01), None
patent: WO 96/21716 (1996-07-01), None
patent: WO 96/30333 (1996-10-01), None
patent: WO 96/40681 (1996-12-01), None
patent: WO 97/30055 (1997-08-01), None
patent: WO 98/22820 (1998-05-01), None
patent: WO 98/47885 (1998-10-01), None
patent: WO 98/56392 (1998-12-01), None
patent: WO 99/05107 (1999-02-01), None
patent: WO 99/23073 (1999-05-01), None
patent: WO 99/47474 (1999-09-01), None
patent: WO 00/06537 (2000-02-01), None
patent: WO 00/14083 (2000-03-01), None
patent: WO 00/27394 (2000-05-01), None
patent: WO 00/27820 (2000-05-01), None
patent: WO 00/35904 (2000-06-01), None
patent: WO 00/42213 (2000-07-01), None
patent: WO 00/61571 (2000-10-01), None
patent: WO 01/16108 (2001-03-01), None
Hansch C. et al. “Hammett Sigmas” in Exploring QSAR Hydrophobic, Electronic and Steric Constants,American Chemical Society: Washington, D.C. pp. 219-304 (1995).
Kinder, D. H. et al., “Synthesis of 2-Amino-3-Boronopropionic Acid: A Boron-Containing Analog of Aspartic Acid”J. Org. Chem., 52(12): 2452-2454 (1987).
Matteson, D. S., et al., “Directed Chiral Synthesis with Pinanediol Boronic Esters”,J. Am. Chem. Soc., 102(25): 7590-7591 (1980).
Ishiyama, T., et al., “Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters”,J. Org. Chem., 60(23): 7508-7510 (1995).
Folch, J. et al., “A Simple Method For The Isolation and Purification of Total Lipides From Animal Tissues”,J. Biol. Chem., 226: 497-509 (1957).
Hall, I. H. et al., “Hypolipidemic, Anti-Obesity, Anti-inflammatory, Anti-osteoporotic, and Anti-neoplastic Properties of Amine Carboxyboranes”,Environ. Health Perspect.102(S3): 21-30 (1994).
Hall, D.G., et al., “N, N-Diethanolaminomethyl Polystyrene: An Efficient Solid Suport to Immobilze Boronic Acids”,Angew. Chem. Int. Ed., 38(20): 3064-3067 (1999).
Gravel, M. et al,. “Universal Solid-Phase Approach for the Immobilization, Derivatization, and Resin-to-Resin Transfer Reactions of Boronic Acids”,J. Org. Chem., 67: 3-15 (2002).
Draffin, S.P., et al., “Highly Fructose Selective Transport Promoted by Boronic Acids Based on a Pentaerythritol Core,”Organic Letters, 3(6): 917-920 (2001).
Reuman, M. et al., “Synthesis and Antibacterial Activity of Some Novel 1-Substituted 1, 4-Dihydro-4-Oxo-7-pyridinyl-3-quinolinecarboxylic acids. Potent Antistaphylococcal Agents.”J. Med. Chem., 38(14): 2531-2540 (1995).
Sakai, M. et al., “Rhodium-Catalyzed Addition of Organoboronic Acids to Aldehydes”,Angew. Chem. Int. Ed.37(23): 3279-3281 (1998).
Barba, V. et al., “Synthesis and Molecular Structures of Dimeric Boron Compounds”,J. Organometallic Chem., 604: 273-282 (2000).
Saito, S. et al., “Synthesis of Biaryls via a Nickel(0)-Catalyzed Cross-Coupling Reaction of Chloroarenes with Arylboronic Acids”,J. Org. Chem.62: 8024-8030 (1997).
Kobayashi, Y. et al., “Preparation of Functionalized Zinc Borates and their Coupling Reaction with Allylic Acetates”,Tetrahedron Lett.39: 7537-7540 (1998).
Aoki, T., et al., “Endothelial cell differentiation into capillary structures by copolymer surfaces with phenylboronic acid groups,”J Biomater Sci: Polymer Edn., 7(7) :539-550, (1995).
Miyazaki, H., et al., “Boronate-Containing Polymer as Novel Mitogen for Lymphocytes,”Biochemical and Biophysical Research Communications, 195(2) ;829-836, (1993).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Aryl boronate functionalized polymers for treating obesity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aryl boronate functionalized polymers for treating obesity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl boronate functionalized polymers for treating obesity will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3541424

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.